| 1 | Study | 1.64% | |
| 2 | Cancer | 0.99% | |
| 3 | Treatment | 0.99% | |
| 4 | Case | 0.99% | |
| 5 | Care | 0.99% | |
| 6 | Elderly | 0.66% | |
| 7 | Left | 0.66% | |
| 8 | Multiple | 0.66% | |
| 9 | Health | 0.66% | |
| 10 | Vaccine | 0.66% | |
| 11 | Diabetes | 0.66% | |
| 12 | Presentation | 0.66% | |
| 13 | Safety | 0.66% | |
| 14 | Detection | 0.66% | |
| 15 | Patients | 0.66% | |
| 16 | Factors | 0.66% | |
| 17 | Weight | 0.66% | |
| 18 | Primary | 0.66% | |
| 19 | Report | 0.66% | |
| 20 | Wall | 0.66% | |
| 21 | Lymphoma | 0.66% | |
| 22 | UK | 0.66% | |
| 23 | GLP-1 | 0.66% | |
| 24 | NHS | 0.66% | |
| 25 | Biomedical | 0.33% | |
| 26 | Offers | 0.33% | |
| 27 | Abdominal | 0.33% | |
| 28 | Titers | 0.33% | |
| 29 | Immune | 0.33% | |
| 30 | Effective | 0.33% | |
| 31 | Demonstrating | 0.33% | |
| 32 | MyPhenome | 0.33% | |
| 33 | Clinical | 0.33% | |
| 34 | ReciBioPharm | 0.33% | |
| 35 | Gut | 0.33% | |
| 36 | Central | 0.33% | |
| 37 | Gain | 0.33% | |
| 38 | Loss | 0.33% | |
| 39 | Target | 0.33% | |
| 40 | Speckle-Tracking | 0.33% | |
| 41 | Traumatic | 0.33% | |
| 42 | Pump | 0.33% | |
| 43 | Proteins | 0.33% | |
| 44 | Risk | 0.33% | |
| 45 | Multimeric | 0.33% | |
| 46 | Uncovers | 0.33% | |
| 47 | Viral | 0.33% | |
| 48 | Antibody | 0.33% | |
| 49 | Syndrome | 0.33% | |
| 50 | Indicator | 0.33% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||